Correlation of Local Interleukin‐1beta Levels with Specific IgA Response Against Gardnerella vaginalis Cytolysin in Women with Bacterial Vaginosis
- 25 April 2002
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 47 (5) , 257-264
- https://doi.org/10.1034/j.1600-0897.2002.01096.x
Abstract
PROBLEM: Mucosal immune system activation may represent a critical determinant of adverse sequelae correlated with bacterial vaginosis, as HIV sexual transmission, upper genital tract infections, cervicitis, endometritis, postsurgical infections, and adverse pregnancy outcomes as preterm delivery (PTD), low birth weight (LBW). METHOD OF STUDY: Levels of interleukin‐1beta (IL‐1beta), anti‐Gardnerella vaginalis hemolysin (Gvh) IgA, pH, Nugent score, and number of leukocytes were measured in vaginal fluids of 60 fertile women with bacterial vaginosis and of 64 healthy controls. RESULTS: Vaginal IL‐1beta levels were nearly 13‐fold higher in women with bacterial vaginosis (BV) and were associated with anti‐Gvh IgA response. IL‐1beta was positively correlated with leukocyte counts in the smear both in healthy and bacterial vaginosis positive women. CONCLUSIONS: Induction of the proinflammatory cytokine IL‐1beta may be a necessary event to elicit an innate immune response to control anaerobic genital tract infections. High levels of vaginal IL‐1beta are associated with mounting of an antigen‐specific mucosal immune response in women with bacterial vaginosis. Parallel induction of innate and adaptive immune response may be associated with protection from ascent of micro‐organisms to the upper genital tract, and from acquiring viral infection through the vaginal tract.Keywords
This publication has 48 references indexed in Scilit:
- Interleukin‐18 Inhibits Human Immunodeficiency Virus Type 1 Production in Peripheral Blood Mononuclear CellsThe Journal of Infectious Diseases, 2001
- RANTES Production from CD4+Lymphocytes Correlates with Host Genotype and Rates of Human Immunodeficiency Virus Type 1 Disease ProgressionThe Journal of Infectious Diseases, 2001
- Interleukin 1 Polymorphisms, Lifestyle Factors, andHelicobacter pyloriInfectionJapanese Journal of Cancer Research, 2001
- Gynecologic conditions and bacterial vaginosis: Implications for the non-pregnant patientInfectious Diseases in Obstetrics and Gynecology, 2000
- High Levels of Tumor Necrosis Factor–α and Interleukin‐1β in Bacterial Vaginosis May Increase Susceptibility to Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2000
- Interleukin-1 and Cutaneous Inflammation: A Crucial Link Between Innate and Acquired ImmunityJournal of Investigative Dermatology, 2000
- IL‐1β, IL‐6, TNFα, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosisActa Obstetricia et Gynecologica Scandinavica, 1998
- Phase 1 Trial of Recombinant Human Interleukin-1β (rhIL-1β), Carboplatin, and Etoposide in Patients with Solid Cancers: Southwest Oncology Group Study 8940Cancer Investigation, 1997
- Specific immune response against Gardnerella vaginalis hemolysin in patients with bacterial vaginosisAmerican Journal of Obstetrics and Gynecology, 1996
- Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic EffectsThe International Journal of Cell Cloning, 1996